SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " much " 3,257 found 🔀 AI-powered Shuffle
DEATH OF SYSTEM FOOTBALL | OPEN THREAD
Welcome to The Daily Merengue! THESE ARE YOUR MODS: Ezek XI, Valyrian Steel, KungFuZizou, NeRObutBlanco, Felipejack, and Juninho LEAST TALENTED This is the least talented generation of footballers we’re seeing world wide. Due to the lack of generational players, teams have adopted what they hope to be a generational system. Generational players are much harder […]
Addison Barger Will Be Out Longer
The start of another series, and all I’m thinking is ‘don’t be swept’. That stuff about Addison Barger being back soon? Not so much. He has a ‘stress reaction in his back’. I guess that means stress fracture, but he’ll be shut down for two more weeks. So let’s hope that he might be back […]
Netflix and Superheroes Are Having a Rough Stretch on Streaming....
(Welcome to my weekly streaming ratings report, the single best guide to what’s popular in streaming TV and what isn’t. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. If you were forwarded this email, please subscribe to get these insights each week.) I have a quick prediction before we start today’s article: You might see this data in future news articles. Not my specific charts or analysis, but the core trend I’ve been monitoring—Netflix is having a lackluster Q2—will become inescapable. Often, folks want to know “What does the data say?” Well, that’s what it says. I haven’t seen this analysis hit the trades really yet, but I have a feeling some other outlets are going to start making this case soon. Remember, you read it here first. You probably have read about the problems facing superhero films at the box office this weekend. Well, this week, I explore whether superheroes are dying on TV as well! And the data says: definitely maybe! We have a lot to cover in today’s Streaming Ratings Report, which covers the two weeks of 18-May and 25-May. Today, I’m just looking at TV, like Netflix’s disappointing Q2, superhero shows underwhelming, a few TV shows dropping off the charts, The Pitt finally ending its epic run on the viewership charts (and whether “view counts” change its status as one of the biggest shows of all time), all the flops, bombs and misses, and a whole lot more. Tomorrow, I’ve got a great rundown of the film side of things. Let’s dive right in! (Reminder: The streaming ratings report focuses on the U.S. market and compiles data from Nielsen’s weekly top ten viewership ranks, Luminate’s Top Ten Data, Showlabs, TV Time trend data, Samba TV household viewership, company datecdotes, Netflix hours viewed data, Google Trends, and IMDb to determine the most popular content. While most data points are current, Nielsen’s data covers the weeks of May 18th to May 31st, 2026. You can find a link to my terminology here.) Subscribe Television - Netflix’s Q2 Slump Continues Having analyzed streaming ratings for going on half a decade, I have learned to trust my gut, but I’m always relieved when I can find actual data to back it up. For example, after a string of very popular shows like Stranger Things, Bridgerton, The Lincoln Lawyer and The Night Agent came out, week after week, in January and February, my gut wondered if Netflix had enough new and returning TV shows to sustain them throughout the year. Since then, Netflix’s post-March slate of shows has not impressed me. This week seemed to feature a potential new hit, but then, like a classic Duffer Bros. TV show, there was a twist. I speak of The Boroughs, Netflix’s latest (and last) Duffer Bros. produced show. The pitch is “Stranger Things with older actors”. And it topped the Nielsen charts: With just two weeks of viewership, The Boroughs would have been a top 25 debut show last year: But here’s the twist: Netflix has already cancelled The Boroughs! What happened? Likely a few things. First, the show didn’t do as well globally as it did in the US. As What’s on Netflix showed, it lagged behind several other shows that got cancelled. Second, its completion rate was likely low; after an initial burst of interest, it quickly dropped off on the Samba TV and Luminate charts. Third, the Duffer Bros. left Netflix for Paramount, and that may have factored into Netflix’s decision here. (Though I tend to believe that if a show is doing well, Netflix would have kept greenlighting seasons.) Still, just because I can explain why Netflix may have cancelled this show doesn’t mean I’m justifying it. In particular, as I’ve noted before, Netflix is losing a lot of their bigger shows as they reach their natural ends, and they need to replace those shows. This show had the hallmarks of a big new genre show, and it’s their biggest hit of the last few months (in the US at least), but now it’s done. Netflix’s other show this week—The Four Seasons, the second season of the “hit” show from last year—definitely disappointed. Its sophomore season had about half the viewership of the first, only 12.7 million hours. It also only had a two week run on Samba TV, and its numbers were all down on Luminate too. In other words, even with two successes, the Q2 slump for Netflix looks real: I could add to the list of disappointments: Both Lord of the Files and Man on Fire had short runs on the Nielsen charts. Running Point’s sophomore season also opened to about half its viewership, similar to The Four Seasons. A Good Girl’s Guide to Murder’s second season—see below—didn’t even make any of the three viewership charts I track, unlike the first season. Netflix is absolutely having a dismal second three months of 2026. If this Nielsen data is any indication, and I think it is, I think this will show up in Netflix’s engagement report, and maybe even their financial outcomes. And the rest of June doesn’t look much better. We have two hit shows coming back—Sweet Magnolias, one of their quietest big shows, and Avatar: The Last Airbender, a big hit for them in 2024—but the other big swings are limited series crime thrillers i.e. no future season potential. Like I said above, sometimes when I uncover a juicy nugget like this, other outlets end up writing very similar articles mimicking the data without credit. We’ll see if that happens this time! Share Television - The State of Superhero Shows on Streaming When I first heard the pitch for Spider-Noir—a Sony TV show on Prime Video that binge-released eight episodes first on MGM+ then on Prime Video two days later—I had my doubts. It’s a live-action Spider-Man show set in the 1930s, starring Nicholas Cage, based on a cameo of a character in Spider-Man: Into the Spider-Verse. No, seriously, that’s the pitch. That could either go terrifically well or horribly wrong. Great because, Spider-Man. He’s the biggest superhero we have. I’ve seen tracking numbers that put the new _Spider-Man: Brand New Da_y as the blockbuster of the year and initial pre-sales back that up. And yet this Spider-Noir pitch feels very esoteric. (Also, the eight-episode binge release feels very “Amazon copying Netflix” again.) So what’s the data say? And what does this say about the future of superhero shows?
Future OLED Macs and iPads could support a much wider color gamut, per report
As Apple gears up to bring OLED to the Mac, a new TrendForce report looks at the wider color gamut reportedly planned for future MacBook Pro, iPad Pro, and iMac displays.
The Six Biggest Questions About ‘GTA VI’
We’ve learned a lot about the most anticipated video game of all time. But much of Rockstar’s blockbuster sequel to ‘Grand Theft Auto V’ remains a mystery.
Hoopaholic’s Gazette: DM, PK, NCAA, WC & BS
So be true to your school now/ Just like you would to your girl (or guy) OK, maybe the wisdom of Brian Wilson doesn’t have much if anything to do with today’s entry. But I did hear it on the radio today, and the Bard of 60s teen culture was all that and fostered us […]
Apple Plans Wider Color Gamut for Future MacBook Pro, iMac, and iPad Pro
Apple plans to adopt OLED panels capable of displaying a much wider range of colors, according to a new report from research firm TrendForce. The new panels would cover 95% of the BT.2020 color standard, which describes a far broader spectrum of colors than the DCI-P3 standard Apple's screens currently target. In practice, that means deeper, more accurate reds, greens, and blues.
Comcast to split cable business from media through NBCUniversal, Sky spinoff
Comcast will split into two publicly traded companies through a spinoff of NBCUniversal and Sky, separating its cash-generating broadband arm from a media and entertainment business under pressure from streaming rivals and industry consolidation. The latest U.S. media industry shake-up follows years of cord-cutting as legacy players chase scale to better compete with Netflix while Paramount Skydance's $110 billion deal for Warner Bros Discovery is set to boost competition. Comcast, which leans on cable for much of its cash flow, is also losing broadband customers to fixed wireless offerings from T-Mobile and Verizon and to fiber rivals building out networks.
Editorial: Feds find more health care fraud
It shouldn’t be too much to ask that taxpayer-funded social service programs benefit people who actually exist.
PS6 Hardware Cost Estimated at $900+
The upcoming Sony PlayStation 6 is slated to launch sometime in 2028, and with recent reports claiming that the ongoing RAM crisis likely won't end or ease up much before then, concerns are mounting about the price of next-gen gaming consoles. Those concerns are seemingly justified, with ubiquitous ...
Baker Mayfield Drops Clear Message on Kyler Murray
As Kyler Murray seeks a fresh start in Minnesota, former teammate Baker Mayfield defends the polarizing quarterback, predicting a dominant resurgence fueled by a much-needed change of scenery.
Andy Burnham’s meteoric rise tells us much about how politics and power are changing
The former may of Greater Manchester’s rise raises questions about the changing dynamics of political parties and leadership in an accelerated political climate.
The PlayStation 6 Reportedly Already Costs $960 in Materials to Manufacture
The PlayStation 6 reportedly costs $960 to build in materials, suggesting next-gen consoles' prices could be much higher than anticipated.
4 Marketing Lessons Every Business Can Learn From the 2026 FIFA World Cup
Nike, Adidas, Home Depot, and FIFA itself offer a powerful reminder: marketing success depends on far more than how much you spend.
Here's How Much A 2022 Cadillac CT4-V Blackwing Has Depreciated In 4 Years
Starting at $60,390 in 2022, the Cadillac CT4-V Blackwing did a solid job at fighting depreciation over the last four years, now trading in the low $50,000s.
A CHAOTIC FINISH TO GROUP G 🤯
A CHAOTIC FINISH TO GROUP G 🤯 See how much the standings changed on Friday night!
5 million have dropped ACA insurance after Trump and the GOP let prices skyrocket
The number of people who signed up for a health plan and then didn't pay their premium fell much more sharply than it has in years past. Trump officials blame fraud. Health policy experts blame costs.
Driving A New Ford Mustang Mach-E After 5 Years Feels So Much Better
The 2026 Ford Mustang Mach-E isn't drastically different from its original 2021 version, but small improvements and a price dip make it a better EV purchase.
50 Cool Charts That Will Make You So Much Smarter
Reading this is like going to college in five minutes.
Americans keep poisoning themselves with semaglutide, other weight loss drugs
These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021.
New iPhone 18 specs report raises big question of iOS 27 limitations
Apple’s base model iPhone 18 might not get as much RAM as expected—raising questions about support for iOS 27’s most demanding features.
Air-conditioning becomes political amid sweltering Europe heatwave
Much of western Europe baked under a “heat dome” as temperatures soar. Authorities warn that the extreme conditions could endanger lives across countries, many of which have limited air conditioning, a topic of which has left the people of Paris divided.
These 15+ award-winning gadgets are on sale for Prime Day - but we'd pay full price
Editor-approved tech is still on sale during Amazon's Prime Day sale - but don't wait much longer to shop.
Hollywood gets into the microdrama race as mobile-first storytelling draws stars and major studios
While much of Hollywood was consumed by the streaming wars, Issa Rae was studying a different mode of entertainment thousands of miles away: microdramas. No stranger to creating a successful online s...
4 Takeaways From USA's Last-Second World Cup Loss To Türkiye
So much for a perfect group stage. But the USA can now turn its attention toward the knockout stages.
What we learned as Bryce Harper caps Phillies' shocking comeback trilogy
The Phillies erased another five-run deficit, rallied late again and reached the season’s halfway point with another reminder of how much has changed.
This Is Probably Your Last Chance to Buy a Cheap MacBook for a While
Apple has dramatically jacked up the price of MacBooks, making the current Prime Day pricing that much more enticing.
Baxter Health Heart and Vascular Clinic Welcomes Brandi Watson, APRN
Baxter Health is proud to welcome Brandi Watson, APRN, to the Baxter Health Heart and Vascular Clinic. Watson joined the team on May 15 and is currently accepting new patients. Watson brings more than 25 years of experience caring for some of the most critically ill patients. Much of her career has been spent in intensive care settings, where she learned to make fast, high-stakes decisions for patients whose lives depended on getting the right care at the right moment. That kind of experience, which is gained through years at the bedside, is exactly what heart and vascular patients need from a provider.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Rubio’s spin on the Iran MOU sounds different from Trump and Vance
For more than a week, America’s top diplomat was conspicuously quiet about something that would have seemed very much in his wheelhouse: a nascent agreement with Iran. But now Secretary of State Marco Rubio is speaking.
Bo McCalebb Inducted into the Allstate Sugar Bowl New Orleans Sports Hall of Fame
NEW ORLEANS — Former University of New Orleans All-American guard Bo McCalebb reiterated how much he loved his time on the Lakefront as he was inducted into the Allstate Sugar Bowl's New Orleans Sports Hall of Fame on Wednesday night.
Myles Garrett's Rise Could Fuel T.J. Watt's Next Steelers Surge
For years, T.J. Watt and Myles Garrett have been linked in one of the NFL's defining player rivalries. Now, with Garrett pulling ahead in recent seasons and Patrick Graham arriving in Pittsburgh, Watt has fresh reasons to respond. For much of their careers, Watt's production far outpaced Garrett's. That changed in 2023 when the Cleveland Browns hired Jim Schwartz as defensive coordinator and Garrett elevated his game to another level.
Semi-communal 'compound houses' in Ghana affect how people participate in political activity
Could the precise architectural form of your residence influence how much you participate in politics? A new study by MIT scholars finds this to be exactly the case—at least in Accra, Ghana, where many ...
Apple raises Mac and iPad prices by as much as 25%
Apple CEO Tim Cook had earlier warned of price increases due to the memory chip shortage.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Zohran Mamdani Tightened His Grip on New York Politics
His opponents thought Tuesday night might offer an opening. It very much did not.
Spurs get expected price tag on potential trade for Celtics’ Jaylen Brown
How much would it cost?
Healthcare Providers Look Beyond Price To Deliver Better Value
A new approach to procurement promises to not just produce much-needed cost savings but also improve outcomes for patients.
Steam Machine Sells Out in Japan Despite Woeful Pricing
As was the case with the Steam Deck, Valve is selling the Steam Machine via Komodo Station, an Asian reseller that serves much of South-East Asia, and as a result, it skips the reservation and lottery system that is currently in place on Valve's own Steam Store. While this doesn't combat issues like...
Health insurers propose high rate hikes for 2027 Minnesota plans
To find out why and how much it'll burden customers, policy analyst Matt McGough with KFF Health News joined Morning Edition Wednesday.
“Cats go wild for this mysterious sound”—why experts say it works every time - Futura-Sciences
The Secret Behind the Slow Blink Cats are famous for their independent streak, but behind that mysterious gaze is a much more complex reality. Our feline friends are constantly seeking ways to communicate with us, but we humans aren’t always the best at picking up their signals. Scientific research has...
The 'pet effect' and how animals may boost your health
Whether you’re the proud pet parent to an animal with paws, claws, hooves or fins, it’s no secret how much joy and companionship they bring us.
Overwatch Fans Revolt Over New Skins That Cost Too Damn Much
The new ‘Ultra’ skins include visual and audio effects, but is that enough?
GTA 6 Ultimate Edition Pre-Order Details Confirm Major New Gameplay Features, Giving Players A First Look At Safehouses And Custom Vehicles
The latest GTA 6 Ultimate Edition news reveals plenty of fresh gameplay details, including fishing, fencing, fixing up classic cars and much more.
Pat Kelsey & The Snub
Sunrise/ Sunset/ Since the beginning it hasn’t changed yet/ People fly high begin to lose sight/ You can’t see very clearly when you’re in flight — “On Your Way Down” Allen Toussaint To be honest I didn’t pay much attention initially when Pat Kelsey was first asked Monday morning about not being invited to attend […]
The hidden stakes of the birthright citizenship case: healthcare for babies
The birthright citizenship case in front of the US Supreme Court is about much more than just citizenship. It’s also about an issue that was little discussed in court arguments: babies’ immediate access to safety net programs and medical tests that need to be done within the first couple days of life.
New Guidebook Helps Puget Sound Beneficiaries Navigate Their Health Care
Great news for military communities and TRICARE beneficiaries across the Pacific Northwest: navigating military healthcare just got easier. The recently released Puget Sound Patient Guidebook is a comprehensive resource designed for local TRICARE beneficiaries throughout the region. Inside, beneficiaries can find information on enrolling in the Defense Enrollment Eligibility Reporting System, understanding TRICARE plans, locating a Military Treatment Facility (MTF), scheduling appointments, accessing online services, ordering medications and much more.
Why South Africa’s leopards shrank to half their normal size
A hidden population of South African leopards has revealed a remarkable evolutionary story. Researchers analyzing entire leopard genomes discovered that the Cape Floristic Region’s leopards are not only much smaller than most African leopards, but also genetically distinct after being isolated for roughly 20,000 years. Surprisingly, despite their small population, they have retained much of their genetic diversity.
Chinese scientists love Blackpink’s Jennie so much they named a fish after her
At less than 9mm, Jennie’s bumblebee goby is the smallest of its genus and the first to be found in China.
Microsoft releases new 13-inch laptop globally with cheaper starting price
Microsoft has released a new version of its Surface Laptop 13-inch. Sold globally, the updated Surface Laptop 13-inch is much cheaper than Microsoft's existing models. Sadly, the device achieves a $200 saving by returning to 8 GB of RAM.
Baltimore businesses hope Sail 250 Maryland will boost sales
Businesses hope Sail 250 Maryland and Air Show Baltimore will bring a much-needed boost in sales.
Roku May Help Fox Avoid Aggregeddon
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Scrolling through links over the last week, I stumbled across this fun headline: Wow. Formula 1 (the sport, not the docu-series) is the perfect “dog not barking”. As a reminder, each week in my Streaming Ratings Report, I call out the shows that miss every viewership chart. I dub them “dogs not barking”—like the Sherlock Holmes mystery—because without any data, we forget they even exist. This is in contrast to something like, say, a film flop—cough The Mandalorian and Grogu cough—where even underperforming at the box office is widely discussed here, there and everywhere. In the US, Formula 1 is now in “no public viewership data, so not discussed” territory. After moving to Apple TV from its former home of ESPN, basically no one talks about it. Apple did publish an initial, unsourced, unsubstantiated, (dare I say unserious) datecdote claiming more folks are watching Formula 1 on Apple than ESPN, but we haven’t gotten any updates since. This stands in contrast to when the sport streamed on ESPN, and ESPN PR provided weekly viewership figures. Formula 1 was, at best, a niche sport in America—averaging 1.3 million viewers in the Big Data Plus era—but now it’s basically anonymous. (And yeah, after moving to Apple, I very, very, very much doubt its ratings increased.) Unfortunately, that story isn’t quite big enough to warrant a section in today’s “Most Important Story of the Week” column, but I wanted to call it out, because otherwise, no one else will! Certainly, no one will write articles about the silence/ratings decline, unlike when they wrote breathless articles connecting the rise in viewership to Netflix’s Drive to Survive, including Reuters just last month. (This is a topic I’ve tried to provide a moderate/nuanced/non-hyped take since 2022.) Anyway, on to this week’s issue. I was a bit worried I didn’t have a juicy topic, then the Murdochs went out and did their Murdoch thing: buying Roku. So that’s the story of the week, and it happens to touch on quite a few themes of the streaming wars and the disruption therein. I’ll cover that, plus why more consolidation in Hollywood media looks likely, more good news on the Hollywood labor front, whether we’ll see an uptick in production in Los Angeles, some Broadway and theme park news, cellphone prices going up in the third world (and possibly everywhere), and more. Subscribe Most Important Story of the Week - Another Big Media & Entertainment Merger The story of the week is clearly Fox is buying Roku for $22 billion. I read a lot of good strategy takes on why Fox bought this streaming TV device maker—and I’ll have mine below—but what fascinates me more is how this deal connects to quite a few themes of the streaming wars, linking to everything from the pace of M&A to “aggregeddon” to Netflix’s recent M&A actions/inactions to the shift to advertising from pure play streaming and more. The only topic I can’t really connect it to is my old theory, “never bet against Rupert Murdoch” because he isn’t the one who did this deal; his son Lachlan inked it. (Do I think he provided advice, even at his 95 years of age? Sure.) That plus I have one additional piece of strategy for all entertainment players, inspired by this deal. So let’s dive into all those topics, starting with why I like this deal. Roku is a Great M&A Buy
Apple's Foldable iPhone Could Lose Almost $1,300 in Value in First Year, Study Suggests
A new resale value study suggests that a $2,000 foldable iPhone could lose as much as $1,292 of its value within its first 12 months on the market, based on current foldable depreciation trends. The estimate comes from SellCell, which analyzed the 12-month resale performance of flagship smartphones from Apple, Samsung, Google, Motorola, and OnePlus.
"The 'AI Stigma' is real and severely punishes developers": A new study shows how much using AI in games hurts sales, and the numbers are hard to believe
Amateur developers might be able to make a quick buck, but established studios are seeing serious declines when using AI during development.
There is belief talented McAtee will flourish at Forest
James McAtee battled to be seen in his debut season at the City Ground, struggling for minutes under Nottingham Forest's four managers. There is belief at the City Ground it is only a matter of time before it comes together for McAtee, despite his struggles. To much excitement from supporters, McAtee arrived on a five-year deal worth about £30m weeks after the under-21s' Euro 2025 triumph.
Learn Science with Dr. V: Does your weight change with location?
How much do you weigh in Ruidoso? Do you think you would weigh the same in places like Corpus Christi or Galveston, which are at sea level?
Dodgers 2, Twins 1: Forgot to pack the runs
The Twins couldn’t muster much against Eric Lauer and the World Series champion Dodgers.
China’s rare earth dominance highlights global supply chain vulnerabilities
China’s dominance in rare earth processing and magnet manufacturing has given it significant influence over global supply chains for products ranging from electric vehicles and wind turbines to consumer electronics and advanced defense systems, The New York Times reports. Although rare earth minerals are mined in several countries, China controls much of the refining and […]
Health equity researchers fear unseen level of scrutiny under White House proposal
Health disparities researchers say a new White House proposal could disqualify much of their work from federal funding — perhaps the most serious threat yet to the future of their field.
Emmet Sheehan struggles again as Orioles rout Dodgers
LOS ANGELES — The Dodgers spent much of the first three months of the season avoiding prolonged slumps, finding ways to win even when certain parts of their game weren’t clicking.
T. rex took 40 years to reach full size, scientists find
Tyrannosaurus rex may have been a much slower grower than scientists realized. A new study of 17 tyrannosaur fossils found that the giant predator likely took about 40 years to reach its full size of roughly eight tons, extending previous estimates by 15 years.
Tybout House owner highlights local business at Council
Victoria Boehmer, owner of Tybout House on Market Street and a leader in several local community initiatives, shared the story behind her business and its growing impact on the region during Monday night’s Warren City Council meeting. Boehmer described Tybout House as much more than a traditional yarn store. The business works closely with local […]
Science Writer Takes Aim at Many Universes Theory
What these speculations point to is the way new findings have destroyed classical materialism. Materialism isn’t so much dying out as breaking up.
France restricts public drinking, sports amid Europe heat wave
France, like much of the rest of Europe, is in the grips of a severe heat wave as summer begins this week, leading to canceled trains, concerts and sports events.
How much preventive health screening should I be getting?
Screenings can find treatable conditions before they’ve caused too much damage – but ‘overscreening’ can cause harm
Long-lived families reveal a rare genetic clue to healthy aging
A study of long-lived families has identified rare genetic variants that may help people stay healthier for much longer as they age. One standout mutation appears to temper inflammation, potentially delaying disease and extending years of healthy living.
Long-lived families reveal a rare genetic clue to healthy aging
A study of long-lived families has identified rare genetic variants that may help people stay healthier for much longer as they age. One standout mutation appears to temper inflammation, potentially delaying disease and extending years of healthy living.
How my dad’s love of the White Sox taught me to look at life and sports differently
Sometimes baseball, and sports in general, is about much more than wins and losses.
US Open payout, purse: How much does each golfer get?
Here's a look at the purse and prize money payouts for the 2026 U.S. Open.
Major review finds vaping likely causes lung and oral cancer
Researchers have concluded that nicotine vapes are likely to cause lung and oral cancers, based on evidence ranging from human biomarkers to animal and laboratory studies. The findings challenge the idea that vaping is a harmless alternative to smoking and suggest health risks may be emerging much sooner than many expected.
UPDATE Primaries 2026: Will Working Families Party Wave Finally Upend Legacy Politics in the Northwest Bronx?
Local voters will no doubt be aware of a growing progressive Democratic movement in the Northwest Bronx, and in The Bronx generally, as in much of New York City over the past several years. Past notable wins have included State Sen. Gustavo Rivera (S.D. 33) in 2010, Congresswoman Alexandria Ocasio-Cortez (NY-14) in 2018, along with former State Sen. Alessandria Biaggi, and former Congressman Jamaal Bowman (NY-16) in 2020.
UPDATE Will Working Families Party Wave Finally Upend Legacy Politics in the Northwest Bronx?
Local voters will no doubt be aware of a growing progressive Democratic movement in the Northwest Bronx, and in The Bronx generally, as in much of New York City over the past several years. Past notable wins have included State Sen. Gustavo Rivera (S.D. 33) in 2010, Congresswoman Alexandria Ocasio-Cortez (NY-14) in 2018, along with former State Sen. Alessandria Biaggi, and former Congressman Jamaal Bowman (NY-16) in 2020.
Will Working Families Party Wave Finally Upend Legacy Politics in the Northwest Bronx?
Local voters will no doubt be aware of a growing progressive Democratic movement in the Northwest Bronx, and in The Bronx generally, as in much of New York City over the past several years. Past notable wins have included State Sen. Gustavo Rivera (S.D. 33) in 2010, Congresswoman Alexandria Ocasio-Cortez (NY-14) in 2018, along with former State Sen. Alessandria Biaggi, and former Congressman Jamaal Bowman (NY-16) in 2020.
Starlink Satellites Are Doing A Lot More Than Just Providing Internet
Starlink is well-known for providing internet to rural areas that could only dream of it at one point. These days, Starlink is doing much more than that.
This DNA repair gene went rogue and exposed a cancer weakness
Scientists have discovered that a gene normally considered a DNA-protecting "good guy" can become dangerous when cells make too much of it. The gene, EXO1, acts like molecular scissors that help repair DNA, but when overproduced it starts cutting DNA it shouldn't, creating damage linked to cancer.
"It helped": Years of Xbox Series S game optimization probably made life much easier for Nintendo Switch 2 developers
Series S optimizations may have given developers valuable experience when bringing modern games to Nintendo Switch 2.
Weekend PC Game Deals: Cyberpunk 2077, Split Fiction, Sonic Racing, and more
This weekend's PC game deals include two wildly different freebies to grab, a whole lot of demos to try out on Steam's latest festival, and much more.
The Market’s AI Fanfare Is Running Into a Harsh Political Reality
Anthropic’s hopes for a blockbuster IPO could depend as much on the ballot box as on investors.
Angels blow seven-run lead in historic fashion to Athletics
The Los Angeles Angels seemed to be on their way to a much-needed, loud victory against the Athletics on Friday night.
Top GOP group pumps $37M into fight on key issue dominating midterm races: 'Much more to come'
American Action Network surpasses $37 million in messaging on cost-of-living issues, highlighting conservative policies ahead of the 2026 midterms.
What is the Nex Playground console, how much is it and when is it out in the UK?
The cube-shaped console will cost £269 (€319) when it is released on 22 June in the UK and Ireland.
Midstate man shares near death experience after health insurance coverage denial
DOVER, Pa. (WHTM) — State lawmakers want to criminalize health insurance companies when their decision to deny coverage seriously injures or kills a patient. A York County man is doing much b…
What is the Pickaway County Fair entertainment?
The Pickaway County Fair may be known best for its livestock judging, but there is so much more! The entertainment aspects to the fair are worth looking into.
U.S. scientific instruments in oceans off Alaska and elsewhere to remain in place
After a public outcry, the National Science Foundation dropped its plan to remove much of the Ocean Observatories Initaitive system.
In season 2 of Sugar, Colin Farrell’s quirky detective becomes much more human
The show’s star talks about keeping secrets, helping John Sugar grow, and why wearing jeans can be so odd.
Earthshine: imaging the Moon for science
This image is part of a series captured by ESA astronaut Sophie Adenot for the European Earthshine experiment, which investigates whether we can measure how much sunlight Earth reflects by using the Moon as a natural projection screen.
We finally know why oldest children do so much better than their younger siblings
For the first time, we have actionable insight into how to make all of our children’s lives better.
Can Better Sleep Lower Dementia Risk? What the Science Says
Poor sleep may raise your Alzheimer's risk by as much as 44%. Here's what researchers know about sleep, brain health, and what you can do tonight.
James Dolan Is a Champion, Much Like His New York Knicks
The so-called Dolan discount evaporated as shares of Madison Square Garden Sports, Madison Square Garden Entertainment, and Sphere Entertainment took wing.
'Adventures of Elliot' review: A fun, frustrating Zelda tribute
It's good, but it had the potential to be so much better.
Intel's stock levels mean investors believe its foundry business will succeed: Bernstein's Rasgon
Stacy Rasgon, Bernstein, and Dan Ives, Wedbush Securities, join 'Power Lunch' to discuss Intel's prospects of building chips in the U.S., Apple price increases and much more.
Marathon Has A New Problem: Players Have Too Much Loot
Bungie is trying to recalibrate the extraction shooter's economy before it's too late
While God of War Laufey Has Plenty of Promise, I Think It’s Sticking Too Close to the Now-Tired Formula of Kratos’ Norse Saga
While God of War Laufey is taking a fascinating leap by shifting the perspective to Faye, it still looks much too similar to Kratos' Norse saga to cement its own identity.
BBC Sport weekly quiz: How long is a World Cup hydration break?
How much attention have you paid to what's happened in the world of sport over the past seven days?
New Plan Scales Back C.D.C.’s Work on Diseases Abroad
The State Department is taking over much of the control of global health initiatives, for which critics say the department does not have the expertise.
Lil Nas X shares update after getting mental health care: ‘There’s less fear in my heart’
Musician says on Instagram he is ‘doing much better’ and receiving treatment and therapy after 2025 arrest
